Austin 2003.
Methods | Study design: ITS | |
Participants | Physicians Clinical speciality: not clear Level of training: fully trained Setting/country: not clear/Canada |
|
Interventions | 2 PEMs were studied, but only 1 respected our inclusion criteria for ITS studies that more than 3 points need to be available before and after the intervention, and that PEM was the HERS. The HERS study was published in 1998 and demonstrated that the risks associated with hormone therapy outweighed the benefits for women taking continuous oestrogen and progestin regimens | |
Outcomes | 2 process outcomes (prescribing):
|
|
Notes | ‐ | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Intervention independent of other changes ‐ ITS | Unclear risk | No information is provided |
Shape of Intervention effect pre‐specified ‐ ITS | Unclear risk | Quote, pg. 3241: "we examined patterns of prescriptions for estrogen replacement therapy (ERT) before and after publication of the Women's Health Initiative (WHI) study on July 17, 2002. We also examined trends around the publication of the Heart and Estrogen/progestin Replacement Study (HERS) in 1998" |
Intervention unlikely to affect data collection ‐ ITS | Low risk | COMMENT: the intervention (publication of the WHI study in 2002) did not affect either the source or method of data collection |
Blinding of outcome assessors (detection bias) ‐ ITS All outcomes | Low risk | The outcome was objective |
Incomplete outcome data (attrition bias) ‐ ITS All outcomes | Low risk | Quote, pg. 3241: "we studied claims for ERT to Ontario's universal Drug Benefit program for seniors (ODB), which tracks medication use by all 1.3 million residents of Ontario older than 65 years" |
Selective reporting (reporting bias) ‐ ITS | Low risk | All relevant outcomes in the methods section were reported in the results section |
Other bias ‐ ITS | Low risk | There was no evidence of other risks of bias |